Study reveals novel insights into Crohn’s disease
The findings by Massachusetts General Hospital could point to a potential target to treat Crohn’s disease.
List view / Grid view
The findings by Massachusetts General Hospital could point to a potential target to treat Crohn’s disease.
An animal study has shown that a modified vaccine for tuberculosis could treat bladder cancer whilst minimising side effects.
A recent genomic surveillance study has demonstrated the value of genomics to inform vaccine design and highlight the challenge posted by shapeshifting bacteria.
Scientists have identified and synthesised a small molecule that could be a more accessible and affective alternative to an antibody that treats a wide range of cancers.
The new RSV vaccine formulation protected newborn mice against infection and evoked strong responses in immune cells from human newborns.
Using cryo-electron microscopy, researchers have captured the structure of a membrane-bound T-cell receptor complex with bound antigen.
The AI algorithm was able to predict the presence and the location of nuclei in more than 8,000 cells.
Researchers found that fibroblasts had varying effects on tumour cells based on both the type of non-small cell lung cancer and the drug used for treatment.
A novel peptide augments the brain’s natural mechanism to help prevent seizures and protect neurons in research models of both Alzheimer’s and epilepsy.
Researchers have developed an mRNA-based cancer vaccine that is delivered directly into the lymphatic system for a more potent response.
Scientists develop a novel single-cell proteomics technique based on water droplet-in-oil digestion to enable efficient protein recovery.
Researchers have developed a machine learning method to quantitatively analyse and compare microscopy images of proteins.
Researchers have discovered that “jumping gene” Lx9c11 has a profound effect on the immune system to virus infection.
12 August 2022 | By
A new technique could relieve pain for individuals with various chronic and neurological conditions.
Researchers have developed a needle-free mucosal bacteriophage (phage) T4-based COVID-19 vaccine is effective against SARS-CoV-2 infection.